Novo Nordisk – Operating Expenses

Quarterly charts & data from official filings

Timeframe

Operating expenses

Operating expensesTable view

Earnings release date
Cost of goods sold
Sales and distribution costs
Research and development costs
Administrative costs
Other operating income and expenses
Total
Earnings release date:04 Aug. 26
Cost of goods sold:
17,100,000,000 kr.+25.8%
Sales and distribution costs:
14,997,000,000 kr.+24.2%
Research and development costs:
17,787,000,000 kr.+73.0%
Administrative costs:
1,309,000,000 kr.+14.8%
Other operating income and expenses:
234,000,000 kr.+120.8%
Total:
51,427,000,000 kr.+38.2%
Earnings release date:06 May. 26
Cost of goods sold:
13,598,000,000 kr.-10.2%
Sales and distribution costs:
12,077,000,000 kr.-24.0%
Research and development costs:
10,284,000,000 kr.-29.8%
Administrative costs:
1,140,000,000 kr.-26.4%
Other operating income and expenses:
106,000,000 kr.-39.1%
Total:
37,205,000,000 kr.-21.5%
Earnings release date:03 Feb. 26
Cost of goods sold:
15,148,000,000 kr.-15.4%
Sales and distribution costs:
15,889,000,000 kr.-0.7%
Research and development costs:
14,648,000,000 kr.-4.8%
Administrative costs:
1,549,000,000 kr.-17.8%
Other operating income and expenses:
174,000,000 kr.+48.7%
Total:
47,408,000,000 kr.-7.6%
Earnings release date:05 Nov. 25
Cost of goods sold:
17,904,000,000 kr.+39.4%
Sales and distribution costs:
15,996,000,000 kr.-8.8%
Research and development costs:
15,393,000,000 kr.+31.7%
Administrative costs:
1,884,000,000 kr.+43.2%
Other operating income and expenses:
117,000,000 kr.+408.7%
Total:
51,294,000,000 kr.+18.2%
Earnings release date:06 Aug. 25
Cost of goods sold:
12,846,000,000 kr.-0.3%
Sales and distribution costs:
17,533,000,000 kr.+17.7%
Research and development costs:
11,690,000,000 kr.+13.4%
Administrative costs:
1,316,000,000 kr.+7.9%
Other operating income and expenses:
23,000,000 kr.+264.3%
Total:
43,408,000,000 kr.+10.5%
Earnings release date:07 May. 25
Cost of goods sold:
12,890,000,000 kr.-1.0%
Sales and distribution costs:
14,892,000,000 kr.-20.4%
Research and development costs:
10,308,000,000 kr.-25.3%
Administrative costs:
1,220,000,000 kr.-22.8%
Other operating income and expenses:
-14,000,000 kr.-100.8%
Total:
39,296,000,000 kr.-19.7%
Earnings release date:05 Feb. 25
Cost of goods sold:
13,024,000,000 kr.+15.2%
Sales and distribution costs:
18,701,000,000 kr.+23.0%
Research and development costs:
13,802,000,000 kr.+45.5%
Administrative costs:
1,580,000,000 kr.+14.3%
Other operating income and expenses:
1,839,000,000 kr.+1720.8%
Total:
48,946,000,000 kr.+30.6%
Earnings release date:06 Nov. 24
Cost of goods sold:
11,308,000,000 kr.+10.1%
Sales and distribution costs:
15,210,000,000 kr.+1.8%
Research and development costs:
9,488,000,000 kr.-41.3%
Administrative costs:
1,382,000,000 kr.+19.4%
Other operating income and expenses:
101,000,000 kr.+124.9%
Total:
37,489,000,000 kr.-11.0%
Earnings release date:07 Aug. 24
Cost of goods sold:
10,274,000,000 kr.+3.6%
Sales and distribution costs:
14,934,000,000 kr.+12.7%
Research and development costs:
16,166,000,000 kr.+87.8%
Administrative costs:
1,157,000,000 kr.+0.0%
Other operating income and expenses:
-405,000,000 kr.-171.3%
Total:
42,126,000,000 kr.+25.7%
Earnings release date:02 May. 24
Cost of goods sold:
9,916,000,000 kr.-1.0%
Sales and distribution costs:
13,256,000,000 kr.-22.8%
Research and development costs:
8,606,000,000 kr.-17.7%
Administrative costs:
1,157,000,000 kr.-20.5%
Other operating income and expenses:
568,000,000 kr.+141.7%
Total:
33,503,000,000 kr.-14.8%
Earnings release date:31 Jan. 24
Cost of goods sold:
10,014,000,000 kr.+3.1%
Sales and distribution costs:
17,170,000,000 kr.+33.9%
Research and development costs:
10,460,000,000 kr.+28.7%
Administrative costs:
1,456,000,000 kr.+15.9%
Other operating income and expenses:
235,000,000 kr.+339.8%
Total:
39,335,000,000 kr.+23.6%
Earnings release date:02 Nov. 23
Cost of goods sold:
9,713,000,000 kr.+23.6%
Sales and distribution costs:
12,819,000,000 kr.-10.6%
Research and development costs:
8,128,000,000 kr.+14.0%
Administrative costs:
1,256,000,000 kr.+17.2%
Other operating income and expenses:
-98,000,000 kr.-753.3%
Total:
31,818,000,000 kr.+4.6%
Earnings release date:10 Aug. 23
Cost of goods sold:
7,856,000,000 kr.-4.0%
Sales and distribution costs:
14,342,000,000 kr.+15.5%
Research and development costs:
7,127,000,000 kr.+5.9%
Administrative costs:
1,072,000,000 kr.+0.1%
Other operating income and expenses:
15,000,000 kr.+145.5%
Total:
30,412,000,000 kr.+7.2%
Earnings release date:04 May. 23
Cost of goods sold:
8,182,000,000 kr.-1.0%
Sales and distribution costs:
12,412,000,000 kr.-9.7%
Research and development costs:
6,728,000,000 kr.-16.8%
Administrative costs:
1,071,000,000 kr.-20.5%
Other operating income and expenses:
-33,000,000 kr.+92.4%
Total:
28,360,000,000 kr.-8.5%
Earnings release date:01 Feb. 23
Cost of goods sold:
8,262,000,000 kr.+14.8%
Sales and distribution costs:
13,743,000,000 kr.+20.0%
Research and development costs:
8,085,000,000 kr.+43.5%
Administrative costs:
1,348,000,000 kr.+16.4%
Other operating income and expenses:
-433,000,000 kr.-621.7%
Total:
31,005,000,000 kr.+22.2%
Earnings release date:02 Nov. 22
Cost of goods sold:
7,200,000,000 kr.
Sales and distribution costs:
11,451,000,000 kr.
Research and development costs:
5,633,000,000 kr.
Administrative costs:
1,158,000,000 kr.
Other operating income and expenses:
-60,000,000 kr.
Total:
25,382,000,000 kr.

Revenue by segment

Revenue by segmentTable view

Earnings release date
Diabetes care
Obesity care
Rare disease
Total
Earnings release date:04 Aug. 26
Diabetes care:
50,429,000,000 kr.-25.9%
Obesity care:
23,152,000,000 kr.-0.8%
Rare disease:
4,907,000,000 kr.-10.1%
Total:
78,488,000,000 kr.-18.9%
Earnings release date:06 May. 26
Diabetes care:
68,019,000,000 kr.+32.5%
Obesity care:
23,343,000,000 kr.+4.0%
Rare disease:
5,461,000,000 kr.+2.1%
Total:
96,823,000,000 kr.+22.3%
Earnings release date:03 Feb. 26
Diabetes care:
51,350,000,000 kr.+4.5%
Obesity care:
22,445,000,000 kr.+6.3%
Rare disease:
5,349,000,000 kr.+13.3%
Total:
79,144,000,000 kr.+5.6%
Earnings release date:05 Nov. 25
Diabetes care:
49,149,000,000 kr.-4.7%
Obesity care:
21,106,000,000 kr.+3.6%
Rare disease:
4,721,000,000 kr.-4.0%
Total:
74,976,000,000 kr.-2.4%
Earnings release date:06 Aug. 25
Diabetes care:
51,566,000,000 kr.-6.3%
Obesity care:
20,372,000,000 kr.+10.6%
Rare disease:
4,919,000,000 kr.+6.5%
Total:
76,857,000,000 kr.-1.6%
Earnings release date:07 May. 25
Diabetes care:
55,044,000,000 kr.-6.0%
Obesity care:
18,424,000,000 kr.-13.9%
Rare disease:
4,619,000,000 kr.-19.0%
Total:
78,087,000,000 kr.-8.9%
Earnings release date:05 Feb. 25
Diabetes care:
58,572,000,000 kr.+22.2%
Obesity care:
21,406,000,000 kr.+13.9%
Rare disease:
5,705,000,000 kr.+24.7%
Total:
85,683,000,000 kr.+20.2%
Earnings release date:06 Nov. 24
Diabetes care:
47,936,000,000 kr.-4.5%
Obesity care:
18,801,000,000 kr.+35.2%
Rare disease:
4,574,000,000 kr.+15.0%
Total:
71,311,000,000 kr.+4.8%
Earnings release date:07 Aug. 24
Diabetes care:
50,180,000,000 kr.+0.5%
Obesity care:
13,904,000,000 kr.+26.0%
Rare disease:
3,976,000,000 kr.-9.3%
Total:
68,060,000,000 kr.+4.1%
Earnings release date:02 May. 24
Diabetes care:
49,930,000,000 kr.-0.3%
Obesity care:
11,035,000,000 kr.-1.7%
Rare disease:
4,384,000,000 kr.-4.1%
Total:
65,349,000,000 kr.-0.8%
Earnings release date:31 Jan. 24
Diabetes care:
50,063,000,000 kr.+17.6%
Obesity care:
11,229,000,000 kr.-8.4%
Rare disease:
4,571,000,000 kr.+17.1%
Total:
65,863,000,000 kr.+12.1%
Earnings release date:02 Nov. 23
Diabetes care:
42,574,000,000 kr.+6.8%
Obesity care:
12,255,000,000 kr.+18.9%
Rare disease:
3,902,000,000 kr.-5.2%
Total:
58,731,000,000 kr.+8.2%
Earnings release date:10 Aug. 23
Diabetes care:
39,880,000,000 kr.-2.6%
Obesity care:
10,306,000,000 kr.+31.4%
Rare disease:
4,114,000,000 kr.-10.1%
Total:
54,300,000,000 kr.+1.7%
Earnings release date:04 May. 23
Diabetes care:
40,949,000,000 kr.+8.5%
Obesity care:
7,842,000,000 kr.+42.9%
Rare disease:
4,576,000,000 kr.-5.7%
Total:
53,367,000,000 kr.+11.0%
Earnings release date:01 Feb. 23
Diabetes care:
37,751,000,000 kr.+4.5%
Obesity care:
5,488,000,000 kr.+26.7%
Rare disease:
4,853,000,000 kr.-5.0%
Total:
48,092,000,000 kr.+5.5%
Earnings release date:02 Nov. 22
Diabetes care:
36,127,000,000 kr.
Obesity care:
4,331,000,000 kr.
Rare disease:
5,108,000,000 kr.
Total:
45,566,000,000 kr.

Revenue by geographic location

Revenue by geographic locationTable view

Earnings release date
North America Operations
US Operations
International Operations
Total
Earnings release date:04 Aug. 26
North America Operations:
–
US Operations:
40,869,000,000 kr.-34.2%
International Operations:
37,619,000,000 kr.+8.5%
Total:
78,488,000,000 kr.-18.9%
Earnings release date:06 May. 26
North America Operations:
–
US Operations:
62,145,000,000 kr.+38.9%
International Operations:
34,678,000,000 kr.+0.8%
Total:
96,823,000,000 kr.+22.3%
Earnings release date:03 Feb. 26
North America Operations:
–
US Operations:
44,743,000,000 kr.+8.7%
International Operations:
34,401,000,000 kr.+1.7%
Total:
79,144,000,000 kr.+5.6%
Earnings release date:05 Nov. 25
North America Operations:
–
US Operations:
41,144,000,000 kr.-4.2%
International Operations:
33,832,000,000 kr.-0.2%
Total:
74,976,000,000 kr.-2.4%
Earnings release date:06 Aug. 25
North America Operations:
–
US Operations:
42,963,000,000 kr.-3.1%
International Operations:
33,894,000,000 kr.+0.4%
Total:
76,857,000,000 kr.-1.6%
Earnings release date:07 May. 25
North America Operations:
–
US Operations:
44,316,000,000 kr.
International Operations:
33,771,000,000 kr.+11.4%
Total:
78,087,000,000 kr.-8.9%
Earnings release date:05 Feb. 25
North America Operations:
55,364,000,000 kr.+30.0%
US Operations:
–
International Operations:
30,319,000,000 kr.+5.6%
Total:
85,683,000,000 kr.+20.2%
Earnings release date:06 Nov. 24
North America Operations:
42,598,000,000 kr.+4.1%
US Operations:
–
International Operations:
28,713,000,000 kr.+5.8%
Total:
71,311,000,000 kr.+4.8%
Earnings release date:07 Aug. 24
North America Operations:
40,930,000,000 kr.+4.2%
US Operations:
–
International Operations:
27,130,000,000 kr.+4.1%
Total:
68,060,000,000 kr.+4.1%
Earnings release date:02 May. 24
North America Operations:
39,280,000,000 kr.-7.8%
US Operations:
–
International Operations:
26,069,000,000 kr.+12.2%
Total:
65,349,000,000 kr.-0.8%
Earnings release date:31 Jan. 24
North America Operations:
42,621,000,000 kr.+21.6%
US Operations:
–
International Operations:
23,242,000,000 kr.-1.9%
Total:
65,863,000,000 kr.+12.1%
Earnings release date:02 Nov. 23
North America Operations:
35,048,000,000 kr.+18.2%
US Operations:
–
International Operations:
23,683,000,000 kr.-3.9%
Total:
58,731,000,000 kr.+8.2%
Earnings release date:10 Aug. 23
North America Operations:
29,663,000,000 kr.+1.2%
US Operations:
–
International Operations:
24,637,000,000 kr.+2.4%
Total:
54,300,000,000 kr.+1.7%
Earnings release date:04 May. 23
North America Operations:
29,297,000,000 kr.+9.9%
US Operations:
–
International Operations:
24,070,000,000 kr.+12.3%
Total:
53,367,000,000 kr.+11.0%
Earnings release date:01 Feb. 23
North America Operations:
26,660,000,000 kr.+12.2%
US Operations:
–
International Operations:
21,432,000,000 kr.-1.7%
Total:
48,092,000,000 kr.+5.5%
Earnings release date:02 Nov. 22
North America Operations:
23,754,000,000 kr.
US Operations:
–
International Operations:
21,812,000,000 kr.
Total:
45,566,000,000 kr.

Profitability

ProfitabilityTable view

Earnings release date
Net income (shareholders)
Free cash flow
Total
Earnings release date:04 Aug. 26
Net income (shareholders):
20,989,000,000 kr.-56.8%
Free cash flow:
42,524,000,000 kr.+232.9%
Total:
63,513,000,000 kr.+3.6%
Earnings release date:06 May. 26
Net income (shareholders):
48,557,000,000 kr.+80.6%
Free cash flow:
12,773,000,000 kr.+218.2%
Total:
61,330,000,000 kr.+281.4%
Earnings release date:03 Feb. 26
Net income (shareholders):
26,891,000,000 kr.+34.4%
Free cash flow:
-10,810,000,000 kr.-133.3%
Total:
16,081,000,000 kr.-69.4%
Earnings release date:05 Nov. 25
Net income (shareholders):
20,006,000,000 kr.-24.5%
Free cash flow:
32,479,000,000 kr.+24.3%
Total:
52,485,000,000 kr.-0.3%
Earnings release date:06 Aug. 25
Net income (shareholders):
26,503,000,000 kr.-8.7%
Free cash flow:
26,124,000,000 kr.+133.9%
Total:
52,627,000,000 kr.+30.9%
Earnings release date:07 May. 25
Net income (shareholders):
29,034,000,000 kr.+2.8%
Free cash flow:
11,169,000,000 kr.+393.9%
Total:
40,203,000,000 kr.+64.6%
Earnings release date:05 Feb. 25
Net income (shareholders):
28,230,000,000 kr.+3.4%
Free cash flow:
-3,800,000,000 kr.-112.0%
Total:
24,430,000,000 kr.-58.6%
Earnings release date:06 Nov. 24
Net income (shareholders):
27,301,000,000 kr.+36.2%
Free cash flow:
31,731,000,000 kr.-20.7%
Total:
59,032,000,000 kr.-1.7%
Earnings release date:07 Aug. 24
Net income (shareholders):
20,050,000,000 kr.-21.1%
Free cash flow:
40,033,000,000 kr.+585.5%
Total:
60,083,000,000 kr.+92.3%
Earnings release date:02 May. 24
Net income (shareholders):
25,407,000,000 kr.+15.7%
Free cash flow:
5,840,000,000 kr.+3955.6%
Total:
31,247,000,000 kr.+41.3%
Earnings release date:31 Jan. 24
Net income (shareholders):
21,963,000,000 kr.-2.3%
Free cash flow:
144,000,000 kr.-99.6%
Total:
22,107,000,000 kr.-61.6%
Earnings release date:02 Nov. 23
Net income (shareholders):
22,478,000,000 kr.+15.7%
Free cash flow:
35,138,000,000 kr.+54.8%
Total:
57,616,000,000 kr.+36.8%
Earnings release date:10 Aug. 23
Net income (shareholders):
19,428,000,000 kr.-1.9%
Free cash flow:
22,699,000,000 kr.-9.6%
Total:
42,127,000,000 kr.-6.2%
Earnings release date:04 May. 23
Net income (shareholders):
19,814,000,000 kr.+45.8%
Free cash flow:
25,121,000,000 kr.+1073.9%
Total:
44,935,000,000 kr.+185.6%
Earnings release date:01 Feb. 23
Net income (shareholders):
13,592,000,000 kr.-5.6%
Free cash flow:
2,140,000,000 kr.-89.8%
Total:
15,732,000,000 kr.-55.6%
Earnings release date:02 Nov. 22
Net income (shareholders):
14,405,000,000 kr.
Free cash flow:
21,009,000,000 kr.
Total:
35,414,000,000 kr.

Profit margin in %

Profit margin in %Table view

Earnings release date
Profit margin (shareholders)
Profit margin (free cash flow)
Earnings release date:04 Aug. 26
Profit margin (shareholders):
26.74 %-23.4 pp
Profit margin (free cash flow):
54.18 %+41.0 pp
Earnings release date:06 May. 26
Profit margin (shareholders):
50.15 %+16.2 pp
Profit margin (free cash flow):
13.19 %+26.9 pp
Earnings release date:03 Feb. 26
Profit margin (shareholders):
33.98 %+7.3 pp
Profit margin (free cash flow):
-13.66 %-57.0 pp
Earnings release date:05 Nov. 25
Profit margin (shareholders):
26.68 %-7.8 pp
Profit margin (free cash flow):
43.32 %+9.3 pp
Earnings release date:06 Aug. 25
Profit margin (shareholders):
34.48 %-2.7 pp
Profit margin (free cash flow):
33.99 %+19.7 pp
Earnings release date:07 May. 25
Profit margin (shareholders):
37.18 %+4.2 pp
Profit margin (free cash flow):
14.3 %+18.7 pp
Earnings release date:05 Feb. 25
Profit margin (shareholders):
32.95 %-5.3 pp
Profit margin (free cash flow):
-4.43 %-48.9 pp
Earnings release date:06 Nov. 24
Profit margin (shareholders):
38.28 %+8.8 pp
Profit margin (free cash flow):
44.5 %-14.3 pp
Earnings release date:07 Aug. 24
Profit margin (shareholders):
29.46 %-9.4 pp
Profit margin (free cash flow):
58.82 %+49.9 pp
Earnings release date:02 May. 24
Profit margin (shareholders):
38.88 %+5.5 pp
Profit margin (free cash flow):
8.94 %+8.7 pp
Earnings release date:31 Jan. 24
Profit margin (shareholders):
33.35 %-4.9 pp
Profit margin (free cash flow):
0.22 %-59.6 pp
Earnings release date:02 Nov. 23
Profit margin (shareholders):
38.27 %+2.5 pp
Profit margin (free cash flow):
59.83 %+18.0 pp
Earnings release date:10 Aug. 23
Profit margin (shareholders):
35.78 %-1.3 pp
Profit margin (free cash flow):
41.8 %-5.3 pp
Earnings release date:04 May. 23
Profit margin (shareholders):
37.13 %+8.9 pp
Profit margin (free cash flow):
47.07 %+42.6 pp
Earnings release date:01 Feb. 23
Profit margin (shareholders):
28.26 %-3.4 pp
Profit margin (free cash flow):
4.45 %-41.7 pp
Earnings release date:02 Nov. 22
Profit margin (shareholders):
31.61 %
Profit margin (free cash flow):
46.11 %

Capital expenditure

Capital expenditureTable view

Earnings release date
Capital expenditure
Earnings release date:04 Aug. 26
Capital expenditure:
12,675,000,000 kr.+12.1%
Earnings release date:06 May. 26
Capital expenditure:
11,311,000,000 kr.-38.6%
Earnings release date:03 Feb. 26
Capital expenditure:
18,429,000,000 kr.+35.2%
Earnings release date:05 Nov. 25
Capital expenditure:
13,628,000,000 kr.-7.0%
Earnings release date:06 Aug. 25
Capital expenditure:
14,661,000,000 kr.+9.2%
Earnings release date:07 May. 25
Capital expenditure:
13,422,000,000 kr.-16.6%
Earnings release date:05 Feb. 25
Capital expenditure:
16,101,000,000 kr.+32.9%
Earnings release date:06 Nov. 24
Capital expenditure:
12,119,000,000 kr.+15.7%
Earnings release date:07 Aug. 24
Capital expenditure:
10,470,000,000 kr.+23.6%
Earnings release date:02 May. 24
Capital expenditure:
8,474,000,000 kr.-9.9%
Earnings release date:31 Jan. 24
Capital expenditure:
9,407,000,000 kr.+61.4%
Earnings release date:02 Nov. 23
Capital expenditure:
5,828,000,000 kr.-0.9%
Earnings release date:10 Aug. 23
Capital expenditure:
5,878,000,000 kr.+25.3%
Earnings release date:04 May. 23
Capital expenditure:
4,693,000,000 kr.-5.4%
Earnings release date:01 Feb. 23
Capital expenditure:
4,961,000,000 kr.+53.6%
Earnings release date:02 Nov. 22
Capital expenditure:
3,230,000,000 kr.